Edan Instruments Inc
Edan Instruments, Inc. engages in the research, development, manufacture, and service of medical electronic equipment and in vitro diagnostic products in China and internationally. The company offers ECG products, including resting ECG, stress test, holter, wireless solution, and ECG workstation products; patient monitoring systems, such as modular and compact patient monitor, vital signs, and te… Read more
Market Cap & Net Worth: Edan Instruments Inc (300206)
Edan Instruments Inc (SHE:300206) has a market capitalization of $1.16 Billion (CN¥8.54 Billion) as of March 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #10173 globally and #2224 in its home market, demonstrating a -0.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Edan Instruments Inc's stock price CN¥14.73 by its total outstanding shares 579663346 (579.66 Million).
Edan Instruments Inc Market Cap History: 2015 to 2026
Edan Instruments Inc's market capitalization history from 2015 to 2026. Data shows growth from $762.76 Million to $1.16 Billion (6.09% CAGR).
Edan Instruments Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Edan Instruments Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.48x
Edan Instruments Inc's market cap is 0.48 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
5.45x
Edan Instruments Inc's market cap is 5.45 times its annual earnings
1.97x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $762.76 Million | $550.14 Million | $103.21 Million | 1.39x | 7.39x |
| 2016 | $662.36 Million | $698.01 Million | $26.35 Million | 0.95x | 25.13x |
| 2017 | $585.14 Million | $843.28 Million | $43.77 Million | 0.69x | 13.37x |
| 2018 | $412.86 Million | $992.72 Million | $92.65 Million | 0.42x | 4.46x |
| 2019 | $519.75 Million | $1.14 Billion | $131.85 Million | 0.46x | 3.94x |
| 2020 | $1.33 Billion | $2.32 Billion | $653.15 Million | 0.57x | 2.03x |
| 2021 | $1.05 Billion | $1.64 Billion | $231.44 Million | 0.64x | 4.53x |
| 2022 | $918.33 Million | $1.74 Billion | $232.94 Million | 0.53x | 3.94x |
| 2023 | $789.82 Million | $1.94 Billion | $221.30 Million | 0.41x | 3.57x |
| 2024 | $883.25 Million | $1.83 Billion | $162.11 Million | 0.48x | 5.45x |
Competitor Companies of 300206 by Market Capitalization
Companies near Edan Instruments Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Edan Instruments Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #79 globally with a market cap of $190.05 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #153 globally with a market cap of $121.18 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #169 globally with a market cap of $112.92 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #191 globally with a market cap of $103.18 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #79 | Abbott Laboratories | NYSE:ABT | $190.05 Billion | $109.95 |
| #153 | Stryker Corporation | NYSE:SYK | $121.18 Billion | $349.56 |
| #169 | Medtronic PLC | NYSE:MDT | $112.92 Billion | $88.24 |
| #191 | Boston Scientific Corp | NYSE:BSX | $103.18 Billion | $69.79 |
Edan Instruments Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Edan Instruments Inc's market cap moved from $762.76 Million to $ 1.16 Billion, with a yearly change of 6.09%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.16 Billion | +15.17% |
| 2025 | CN¥1.01 Billion | +14.40% |
| 2024 | CN¥883.25 Million | +11.83% |
| 2023 | CN¥789.82 Million | -13.99% |
| 2022 | CN¥918.33 Million | -12.43% |
| 2021 | CN¥1.05 Billion | -21.06% |
| 2020 | CN¥1.33 Billion | +155.57% |
| 2019 | CN¥519.75 Million | +25.89% |
| 2018 | CN¥412.86 Million | -29.44% |
| 2017 | CN¥585.14 Million | -11.66% |
| 2016 | CN¥662.36 Million | -13.16% |
| 2015 | CN¥762.76 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Edan Instruments Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.16 Billion USD |
| MoneyControl | $1.16 Billion USD |
| MarketWatch | $1.16 Billion USD |
| marketcap.company | $1.16 Billion USD |
| Reuters | $1.16 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.